Bioventus's total assets for Q4 2024 were $727.96M, a decrease of -5.40% from the previous quarter. BVS total liabilities were $542.35M for the fiscal quarter, a -6.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.